3D Imaging Drug Design & Development LLC
Little Rock, AR Doing business as 3D Imaging Drug Design & Development LLC 3D Imaging LLC
- UEI
- W1SFM4QYMTV5
- CAGE
- 4V2L0
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Partnership or Limited Liability Partnership
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 9015 Carti Way, Little Rock, AR 72205, USA
- Website
- 3dimagingllc.com
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Industrials
- Commercial & Professional Services
- Professional Services
- SIC code
- 89 Services, Not Elsewhere Classified
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| [18F] dfnsh radiotracers to include synthesis and delivery | Food and Drug Administration | $100,000 | |
| Synthesis and delivery of dfnsh radiotracer | Food and Drug Administration | $31,500 | |
| Synthesis/delivery of dfnsh radiotracer | Food and Drug Administration | $31,500 | |
| Radiotracer synthesis development services | Food and Drug Administration | $1,649,083 | |
| Research, development and synthesis of radioactive labeled tracers cap nctr-11-021 | Food and Drug Administration | $1,095,484 |
About 3D Imaging Drug Design & Development LLC
3D Imaging Drug Design & Development LLC is a partnership or limited liability partnership business registered to receive federal awards since 2007. It is a for-profit limited liability company that specializes in using imaging tools for drug design and development, providing radionuclides, radiopharmaceuticals, and customized research services, according to its website description.
Through past federal contract awards from the Department of Health and Human Services Food and Drug Administration, 3D Imaging Drug Design & Development LLC has provided radiotracers including synthesis and delivery services to support the FDA's research efforts in imaging and drug development. The company received a $100,000 firm fixed price purchase order in June 2023 with a total small business set-aside designation for these radiotracer services through October 2023. Prior awards in 2020 and 2019 from the FDA valued at $31,500 each were for similar synthesis and delivery of DFNSH radiotracer compounds with no set-aside designations. These contracts highlight 3D Imaging's role as a specialized provider of radiopharmaceuticals and related services through firm fixed price purchase orders to enable medical research and drug development activities for the federal government.
SBA capabilities narrative
Custom radiolabeling of drug candidates and imaging probes for PET and SPECT. Imaging for drug evaluation. PET studies of: inhaled drugs, receptor status, drug distribution. Clinical imaging studies through collaboration with academic partners.
Quick answers
What is 3D Imaging Drug Design & Development LLC's UEI?
3D Imaging Drug Design & Development LLC's Unique Entity ID (UEI) in SAM.gov is W1SFM4QYMTV5.
What is 3D Imaging Drug Design & Development LLC's CAGE code?
3D Imaging Drug Design & Development LLC's CAGE code is 4V2L0.
What is 3D Imaging Drug Design & Development LLC's primary NAICS code?
3D Imaging Drug Design & Development LLC's primary NAICS code is 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)).
Where is 3D Imaging Drug Design & Development LLC located?
3D Imaging Drug Design & Development LLC's physical address in SAM.gov is 9015 Carti Way, Little Rock, AR 72205, USA.
Is 3D Imaging Drug Design & Development LLC registered in SAM.gov?
Yes. 3D Imaging Drug Design & Development LLC's SAM.gov registration is active through March 16, 2027.
What is 3D Imaging Drug Design & Development LLC's most recent federal award?
3D Imaging Drug Design & Development LLC's most recent federal contract award is [18F] dfnsh radiotracers to include synthesis and delivery (75F40123P00196), from Food and Drug Administration, on June 15, 2023.
On GovTribe
See 3D Imaging Drug Design & Development LLC's full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors